Home > Insider Trading > Filing (0001708138-21-000014)

Filing Details

Accession Number:: 0001708138-21-000014
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-02-02 16:06:50
Reporting Period:: 2021-02-01

Accepted Time:: 2021-02-02 16:06:50
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
872589	Regeneron Pharmaceuticals Inc.	REGN	Pharmaceutical Preparations (2834)	133444607

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1187443	F Arthur Ryan	777 Old Saw Mill River Road Tarrytown NY 10591		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2021-02-01	9	$504.68	23,782	No	4	S	Direct
Common Stock	Disposition	2021-02-01	17	$505.60	23,765	No	4	S	Direct
Common Stock	Disposition	2021-02-01	30	$506.44	23,735	No	4	S	Direct
Common Stock	Disposition	2021-02-01	22	$507.39	23,713	No	4	S	Direct
Common Stock	Disposition	2021-02-01	16	$508.52	23,697	No	4	S	Direct
Common Stock	Disposition	2021-02-01	4	$509.28	23,693	No	4	S	Direct
Common Stock	Disposition	2021-02-01	2	$512.82	23,691	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
Represents volume-weighted average price of sales of 9 shares of Company stock on February 1, 2021 at prices ranging from $504.32 to $504.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2021 at each separate price.
Represents volume-weighted average price of sales of 17 shares of Company stock on February 1, 2021 at prices ranging from $505.14 to $505.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2021 at each separate price.
Represents volume-weighted average price of sales of 30 shares of Company stock on February 1, 2021 at prices ranging from $506.00 to $506.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2021 at each separate price.
Represents volume-weighted average price of sales of 22 shares of Company stock on February 1, 2021 at prices ranging from $507.00 to $507.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2021 at each separate price.
Represents volume-weighted average price of sales of 16 shares of Company stock on February 1, 2021 at prices ranging from $508.01 to $508.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2021 at each separate price.
Represents volume-weighted average price of sales of 4 shares of Company stock on February 1, 2021 at prices ranging from $509.14 to $509.67. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2021 at each separate price.